Literature DB >> 17893130

Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.

Tricia L Humphreys1, Lang Li, Xiaoman Li, Diane M Janowicz, Kate R Fortney, Qianqian Zhao, Wei Li, Jeanette McClintick, Barry P Katz, David S Wilkes, Howard J Edenberg, Stanley M Spinola.   

Abstract

In experimentally infected human volunteers, the cutaneous immune response to Haemophilus ducreyi is orchestrated by serum, polymorphonuclear leukocytes, macrophages, T cells, and myeloid dendritic cells (DC). This response either leads to spontaneous resolution of infection or progresses to pustule formation, which is associated with the failure of phagocytes to ingest the organism and the presence of Th1 and regulatory T cells. In volunteers who are challenged twice, some subjects form at least one pustule twice (PP group), while others have all inoculated sites resolve twice (RR group). Here, we infected PP and RR subjects with H. ducreyi and used microarrays to profile gene expression in infected and wounded skin. The PP and RR groups shared a core response to H. ducreyi. Additional transcripts that signified effective immune function were differentially expressed in RR infected sites, while those that signified a hyperinflammatory, dysregulated response were differentially expressed in PP infected sites. To examine whether DC drove these responses, we profiled gene expression in H. ducreyi-infected and uninfected monocyte-derived DC. Both groups had a common response that was typical of a type 1 DC (DC1) response. RR DC exclusively expressed many additional transcripts indicative of DC1. PP DC exclusively expressed differentially regulated transcripts characteristic of DC1 and regulatory DC. The data suggest that DC from the PP and RR groups respond differentially to H. ducreyi. PP DC may promote a dysregulated T-cell response that contributes to phagocytic failure, while RR DC may promote a Th1 response that facilitates bacterial clearance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893130      PMCID: PMC2168359          DOI: 10.1128/IAI.00777-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  85 in total

1.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 2.  Tolerance signaling molecules.

Authors:  David A Clark
Journal:  Chem Immunol Allergy       Date:  2005

Review 3.  The macrophage scavenger receptor CD163.

Authors:  Babs O Fabriek; Christine D Dijkstra; Timo K van den Berg
Journal:  Immunobiology       Date:  2005       Impact factor: 3.144

4.  Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling.

Authors:  Jason R Mock; Merja Vakevainen; Kaiping Deng; Jo L Latimer; Jennifer A Young; Nicolai S C van Oers; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers.

Authors:  Diane Janowicz; Isabelle Leduc; Kate R Fortney; Barry P Katz; Christopher Elkins; Stanley M Spinola
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Oxidative stress in sepsis: a redox redux.

Authors:  Jay K Kolls
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Proteome of Haemophilus ducreyi by 2-D SDS-PAGE and mass spectrometry: strain variation, virulence, and carbohydrate expression.

Authors:  N Karoline Scheffler; Arnold M Falick; Steven C Hall; William C Ray; Deborah M Post; Robert S Munson; Bradford W Gibson
Journal:  J Proteome Res       Date:  2003 Sep-Oct       Impact factor: 4.466

9.  Effects of filtering by Present call on analysis of microarray experiments.

Authors:  Jeanette N McClintick; Howard J Edenberg
Journal:  BMC Bioinformatics       Date:  2006-01-31       Impact factor: 3.169

10.  Reproducibility of oligonucleotide arrays using small samples.

Authors:  Jeanette N McClintick; Ronald E Jerome; Charles R Nicholson; David W Crabb; Howard J Edenberg
Journal:  BMC Genomics       Date:  2003-01-30       Impact factor: 3.969

View more
  16 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages.

Authors:  Wei Li; Barry P Katz; Margaret E Bauer; Stanley M Spinola
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

3.  Genome-based expression profiling study of Hunner's ulcer type interstitial cystitis: an array of 40-gene model.

Authors:  Ling-Hong Tseng; Ilene Chen; Chao-Nin Wang; Yi-Hao Lin; L Keith Lloyd; Chyi-Long Lee
Journal:  Int Urogynecol J       Date:  2010-03-04       Impact factor: 2.894

4.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

5.  Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

6.  Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

7.  Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans.

Authors:  William E Yang; Sunil Suchindran; Bradly P Nicholson; Micah T McClain; Thomas Burke; Geoffrey S Ginsburg; Clayton D Harro; Subhra Chakraborty; David A Sack; Christopher W Woods; Ephraim L Tsalik
Journal:  J Infect Dis       Date:  2016-01-18       Impact factor: 5.226

8.  Mechanism of human natural killer cell activation by Haemophilus ducreyi.

Authors:  Wei Li; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

9.  Haemophilus ducreyi partially activates human myeloid dendritic cells.

Authors:  Keith E Banks; Tricia L Humphreys; Wei Li; Barry P Katz; David S Wilkes; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

10.  Host Polymorphisms in TLR9 and IL10 Are Associated With the Outcomes of Experimental Haemophilus ducreyi Infection in Human Volunteers.

Authors:  Martin Singer; Wei Li; Servaas A Morré; Sander Ouburg; Stanley M Spinola
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.